Samuel A Hamood
CIK 1645772 · EVP & CFO · last filed 2026-06-09
Samuel A Hamood is an EVP & CFO who has filed 19 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for DH, was dated Jun 9, 2026. Across all open-market trades the lifetime net is −$19.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.22M
4
19
-$19.51M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DH | Director | 340,978 | $0.84 | $286.3K | $0 | 5 | 2026-06-09 |
| NIQ | Director | 47,267 | $8.27 | $390.9K | $0 | 2 | 2026-06-01 |
| Finch Therapeutics Group, Inc. (FNCH) Delisted | Director | — | $7.30 | — | $0 | 2 | 2022-06-15 |
| TRU | EVP & CFO | 98,968 | $66.13 | $6.54M | -$19.51M | 10 | 2017-09-18 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-09 | DH | Grant (A) | +189,190 | $0 | EDGAR |
| 2026-06-01 | NIQ | Grant (A) | +22,182 | $0 | EDGAR |
| 2025-08-22 | NIQ | Grant (A) | +1,736 | $0 | EDGAR |
| 2025-06-09 | DH | Grant (A) | +55,911 | $0 | EDGAR |
| 2024-05-24 | DH | Grant (A) | +26,759 | $0 | EDGAR |
| 2023-06-08 | DH | Grant (A) | +17,536 | $0 | EDGAR |
| 2022-06-15 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | DH | Grant (A) | +14,545 | $0 | EDGAR |
| 2021-10-05 | Finch Therapeutics Group, Inc. (FNCH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-09-18 | TRU | Mixed | +18,844 | -$716.1K | EDGAR |